About IMMUNOCORE COMMERCIAL LLC
Immunocore Holdings plc is a commercial-stage biotechnology company focused on developing and commercializing T cell receptor (TCR) therapies to improve patient outcomes in cancer, infectious diseases, and autoimmune diseases. The company utilizes its proprietary ImmTAX technology to activate or modulate the immune system.
Recent Federal Awards
| Award | Agency | Amount | Date |
|---|---|---|---|
| KIMMTRAK (TEBENTAFUSP-TEBN) 100MCG/0.5ML VIAL,INJ NDC: 80446-0401-01 | Department of Veterans Affairs | $29K | |
| KIMMTRAK | Department of Veterans Affairs | $14K | |
| KIMMTRAK | Department of Veterans Affairs | $87K | |
| KIMMTRACK 100 MCG/0.5 ML VIAL INJECTION | Department of Veterans Affairs | $15K | |
| KIMMTRAK | Department of Veterans Affairs | $44K |
Is this your company?
Claim IMMUNOCORE COMMERCIAL LLC to unlock the federal & state contracts GovIntel's AI has matched to you right now — plus your own scored past-performance, who you're up against, and who's risky to team with.
Claim IMMUNOCORE COMMERCIAL LLC & see your matchesFree to claim. Takes about a minute.
Data compiled from public government sources including SAM.gov, USAspending.gov, and state procurement records. Last verified against federal award records. Inaccurate, or want this page removed? Request a correction or removal.